Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exome | 8 | 2021 | 127 | 1.230 |
Why?
|
| Genetic Testing | 5 | 2023 | 537 | 0.830 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 39 | 0.490 |
Why?
|
| Physicians | 1 | 2021 | 689 | 0.460 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 177 | 0.450 |
Why?
|
| Genetic Variation | 4 | 2018 | 1371 | 0.400 |
Why?
|
| Genomics | 4 | 2023 | 761 | 0.390 |
Why?
|
| Computational Biology | 1 | 2014 | 542 | 0.380 |
Why?
|
| Intellectual Disability | 3 | 2016 | 189 | 0.350 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2008 | 13 | 0.330 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2008 | 35 | 0.320 |
Why?
|
| Neuropeptides | 1 | 2008 | 114 | 0.310 |
Why?
|
| Gene Duplication | 1 | 2008 | 126 | 0.300 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 184 | 0.300 |
Why?
|
| Gene Deletion | 1 | 2008 | 342 | 0.290 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 101 | 0.270 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 481 | 0.260 |
Why?
|
| Gallstones | 1 | 2004 | 15 | 0.240 |
Why?
|
| Glucuronosyltransferase | 2 | 2010 | 186 | 0.240 |
Why?
|
| Fabry Disease | 1 | 2023 | 6 | 0.230 |
Why?
|
| Mutation, Missense | 2 | 2015 | 277 | 0.230 |
Why?
|
| Cohort Studies | 3 | 2021 | 2863 | 0.210 |
Why?
|
| Phenotype | 4 | 2018 | 2439 | 0.210 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 144 | 0.200 |
Why?
|
| De Lange Syndrome | 2 | 2013 | 10 | 0.200 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 204 | 0.200 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2021 | 19 | 0.190 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 529 | 0.180 |
Why?
|
| Genome | 1 | 2023 | 386 | 0.170 |
Why?
|
| Genetics, Medical | 1 | 2019 | 52 | 0.160 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 6 | 0.160 |
Why?
|
| Hypopituitarism | 1 | 2018 | 19 | 0.160 |
Why?
|
| Cleft Palate | 1 | 2018 | 26 | 0.160 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 19 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 2335 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 91 | 0.150 |
Why?
|
| Humans | 23 | 2023 | 89073 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 294 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 763 | 0.140 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 42 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 43 | 0.130 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2015 | 42 | 0.130 |
Why?
|
| Genotype | 4 | 2010 | 1848 | 0.130 |
Why?
|
| Bartter Syndrome | 1 | 2015 | 3 | 0.130 |
Why?
|
| Transaminases | 1 | 2015 | 33 | 0.130 |
Why?
|
| Chloride Channels | 1 | 2015 | 42 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2015 | 101 | 0.120 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 64 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 264 | 0.120 |
Why?
|
| Sudden Infant Death | 1 | 2015 | 27 | 0.120 |
Why?
|
| Mutation | 6 | 2016 | 4132 | 0.120 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 97 | 0.120 |
Why?
|
| DNA | 2 | 2014 | 1307 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 234 | 0.120 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2013 | 5 | 0.120 |
Why?
|
| Micrognathism | 1 | 2013 | 11 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2015 | 185 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 324 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 866 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 401 | 0.090 |
Why?
|
| Glucuronides | 1 | 2010 | 34 | 0.090 |
Why?
|
| Proteins | 2 | 2013 | 786 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 51 | 0.090 |
Why?
|
| Adult | 5 | 2021 | 26508 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 643 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 35 | 0.090 |
Why?
|
| Female | 11 | 2023 | 46014 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 59 | 0.080 |
Why?
|
| Warfarin | 1 | 2009 | 104 | 0.080 |
Why?
|
| Genes | 1 | 2008 | 305 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1670 | 0.070 |
Why?
|
| Male | 9 | 2021 | 42254 | 0.070 |
Why?
|
| Base Sequence | 2 | 2015 | 2327 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1875 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2009 | 426 | 0.070 |
Why?
|
| Dairying | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lactose | 1 | 2005 | 27 | 0.060 |
Why?
|
| Agriculture | 1 | 2005 | 39 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 9237 | 0.060 |
Why?
|
| Age of Onset | 1 | 2004 | 312 | 0.060 |
Why?
|
| DNA Primers | 1 | 2004 | 543 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 86 | 0.060 |
Why?
|
| Alleles | 2 | 2018 | 1135 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1837 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 161 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2005 | 405 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 9003 | 0.050 |
Why?
|
| Direct-To-Consumer Screening and Testing | 1 | 2021 | 1 | 0.050 |
Why?
|
| Jews | 1 | 2021 | 42 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 956 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2018 | 685 | 0.050 |
Why?
|
| Aging | 1 | 2004 | 716 | 0.040 |
Why?
|
| Child | 2 | 2016 | 7149 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 415 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 27 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 34 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 3717 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2476 | 0.040 |
Why?
|
| Research | 1 | 2019 | 252 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2018 | 46 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 6289 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2752 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 478 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2014 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2015 | 24 | 0.030 |
Why?
|
| Homozygote | 1 | 2015 | 204 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 280 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 2291 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 73 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 71 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 373 | 0.030 |
Why?
|
| Autopsy | 1 | 2015 | 122 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 449 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 208 | 0.030 |
Why?
|
| Siblings | 1 | 2015 | 111 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 240 | 0.030 |
Why?
|
| Medicine | 1 | 2015 | 91 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 636 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 299 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 196 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 338 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 4273 | 0.030 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2013 | 2 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 2011 | 0.030 |
Why?
|
| Cause of Death | 1 | 2015 | 266 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 110 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 969 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 152 | 0.030 |
Why?
|
| Zebrafish | 1 | 2015 | 319 | 0.030 |
Why?
|
| United States | 2 | 2019 | 6957 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 5466 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 359 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 49 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3027 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 128 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1715 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 28 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 352 | 0.020 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25865 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 217 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 590 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 69 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 3147 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 135 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1528 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 887 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 443 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 3010 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1063 | 0.020 |
Why?
|
| Lactose Tolerance Test | 1 | 2005 | 2 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2657 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 2281 | 0.020 |
Why?
|
| Milk | 1 | 2005 | 53 | 0.020 |
Why?
|
| Africa | 1 | 2005 | 101 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 48 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1157 | 0.020 |
Why?
|
| Europe | 1 | 2005 | 321 | 0.010 |
Why?
|
| Haplotypes | 1 | 2005 | 637 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 27324 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2399 | 0.010 |
Why?
|